Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Wednesday, July 30th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $292.67 million for the quarter.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 1.41% and a positive return on equity of 2.56%. The firm's quarterly revenue was down 22.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.19 earnings per share. On average, analysts expect Cross Country Healthcare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Cross Country Healthcare Stock Performance
CCRN traded up $0.01 during midday trading on Friday, hitting $13.60. The company had a trading volume of 346,908 shares, compared to its average volume of 222,693. The company has a market capitalization of $445.81 million, a PE ratio of -25.66, a P/E/G ratio of 4.25 and a beta of 0.36. Cross Country Healthcare has a twelve month low of $9.58 and a twelve month high of $18.50. The firm's 50-day simple moving average is $13.18 and its 200-day simple moving average is $15.03.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Cross Country Healthcare stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 7.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 115,823 shares of the business services provider's stock after acquiring an additional 8,490 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.35% of Cross Country Healthcare worth $1,725,000 as of its most recent SEC filing. Institutional investors own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Barrington Research reiterated a "market perform" rating and set a $18.61 price target on shares of Cross Country Healthcare in a research report on Tuesday, June 17th. Wall Street Zen assumed coverage on shares of Cross Country Healthcare in a research report on Thursday, May 15th. They set a "hold" rating for the company. Finally, UBS Group lowered their price target on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Seven investment analysts have rated the stock with a hold rating, According to MarketBeat, Cross Country Healthcare presently has a consensus rating of "Hold" and an average price target of $17.93.
Get Our Latest Research Report on Cross Country Healthcare
Cross Country Healthcare Company Profile
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.